Since the NLRP3 inflammasome is also involved in the pathogenesis of IBD [90], in the last few years, the idea of targeting it as a therapeutic strategy in these inflammatory disorders has gained increasing attention [83]. Here, NLRP3 is linked to inflammatory bowel disease.